Consensus interferon treatment for Pegylated interferon relapsers Hepatitis C patients rated the best study by Pakistan Society of Gastroenterology Annual conference in Bhurbun Muree May 30th 2010.

Chronic Hepatitis C treatment is a rapidly changing arena. There are rapidly changing guidelines about the type of interferon use and duration of treatment. We are able to understand the disease process better after 20 years of research to improve the diagnostic tools and treatment type and duration. There are new tools and parameters, both […]

Dr. Gill is invited to the International Liver CongressTM 2010 by EASL, taking place in Vienna, Austria, April 14 to 18, 2010. On behalf of the Scientific Programme Committee, we are very pleased to inform you that your abstract A-248-0025-00251 entitled: "RAPID VIROLOGICAL RESPONSE IS A PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEP C […]

Dr. Gill is invited to the 20th Conference of the APASL, to be held at the China National Convention Center, 25 to 28 March 2010, Beijing, China. Thank you very much for submitting abstract(s) to the 20th Conference of the APASL. On behalf of the Scientific Committee, we are pleased to inform you that your […]

New treatment for hep c non responders and relapsers

Treatment Challenges Of Hepatitis C Non Responders And Relapsers Treatment Challenges Of Hepatitis C Non Responders And Relapsers. Invited lecture on December 12th 2009 in Karachi for Asia pacific association for study of liver diseases.